Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
33 hedge funds and large institutions have $10.4M invested in Psychemedics Corporation in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 4 closing their positions.
3% more capital invested
Capital invested by funds: $10M → $10.4M (+$336K)
3% less funds holding
Funds holding: 34 → 33 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
81% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$141K |
| 2 |
SMP
Santa Monica Partners
Palm Beach Gardens,
Florida
|
+$86.8K |
| 3 |
GI
GS Investments
Minneapolis,
Minnesota
|
+$39.1K |
| 4 |
Morgan Stanley
New York
|
+$10.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$782K |
| 2 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$238K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$97.7K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$55K |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$47.7K |
PMD Hedge Fund Activity: Q4 2020 in Review
33 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2020, worth a combined $10.4M — up 3.3% from $10M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PMD and 3 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 3 added.
The largest buyer was Invenomic Capital Management, adding an estimated $141K. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $782K sold.
- 33 institutional investors held Psychemedics Corporation (PMD) as of Q4 2020, down from 34 in Q3 2020.
- Funds reported $10.4M of Psychemedics Corporation stock for Q4 2020, up 3.3% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q4 2020 and 4 closed out, a net change of -1 holder.
- The largest Psychemedics Corporation buyer in Q4 2020 was Invenomic Capital Management, an estimated $141K added.
- The largest Psychemedics Corporation seller in Q4 2020 was Kennedy Capital Management, an estimated $782K sold.
Based on aggregated 13F filings for Q4 2020.